Last updated 2026-07-20
- Raised $80M Undisclosed Round, Sep 2015
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
HighCape Partners is a growth equity fund that invests in commercial-stage life sciences companies. The firm applies decades of combined investment and operational experience to help transform its portfolio companies into sustainable businesses with multiple exit alternatives. They focus on companies in connected health, medical devices/tools, and biotechnology, providing strategic, operational, and commercial support.
Portfolio
No portfolio companies in this dataset yet.
Investment activity
1 portfolio exit on record.
Portfolio by sector
Health Tech & Life Sciences1
Q&A
- What is HighCape Partners' most notable exit?
- HighCape Partners notably exited Cheetah Medical in September 2019 through an acquisition by Baxter International for $230M.
- Which sectors does HighCape Partners focus on for investments?
- HighCape Partners shows a concentration in the Health Tech & Life Sciences sector, with all its portfolio companies and exits falling within this area.
- Can you name a key portfolio company for HighCape Partners?
- A key portfolio company for HighCape Partners was Cheetah Medical, which specializes in noninvasive fluid management technologies.
- When was HighCape Partners founded?
- HighCape Partners was founded in 2019.
- What is the typical investment range for HighCape Partners?
- HighCape Partners typically invests between $5M and $11.76M.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2013 |
|---|